After years of shrinking the prominence of commercial real estate in its portfolio, M&T Bank has hit its target and begun to ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Rigel (RIGL – Research Report). The associated price target ...

Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...

Replimune Group Inc (NASDAQ:REPL), a biotechnology company specializing in oncolytic immunotherapy for cancer treatment with a current market capitalization of $803 million, has been making ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and ...

Marla has worked in the healthcare industry since 2000, starting as a bench chemist with Pfizer in manufacturing. In 2006, ...

On November 22, 2024, the U.S. Food and Drug Administration approved Attruby, a near-complete TTR stabilizer, to reduce cardiovascular death and cardiovascular-related hospitalization in adult ...

WARREN, N.J., Jan. 13, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today provided an update on the Company's progress and its outlook for 2025. Matthew ...

Novartis will assume global development, manufacturing and commercial responsibilities following the completion of the placebo-controlled portion of PIVOT-HD, which is expected in 1H 2025.

U.S. commercial crude oil stocks excluding the Strategic Petroleum Reserve fell by 2M barrels to 412.7 million barrels in the week ended January 10 and were ~6% below the five-year average for the ...

Johnson & Johnson acquires Intra-Cellular Therapies for $14.6 billion. The biggest driver was the rights Caplyta which has ...